ARCHIVES

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

This article is from The Cancer Letter archive.

Vol. 07 No. 24 | June 12, 1981

Download PDF Visit The Full Archive

Related Articles

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

CTEP Deploys Website To Track Trial Activation

December 10, 2010

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Harkin to Ask NCI For Accounting Of Antineoplaston Trials

July 2, 1993

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008